Epidemiology and Clinical Features of Herpes-zoster Meningoencephalitis.
- Author:
Jong Kyu KIM
1
;
Yea Son LEE
;
Chan Ho NA
;
Min Sung KIM
;
Bong Seok SHIN
Author Information
1. Department of Neurology, Chosun University School of Medicine, Gwangju, Korea.
- Publication Type:Original Article
- Keywords:
Herpes zoster;
Meningoencephalitis
- MeSH:
Acute Pain;
Acyclovir;
Age Distribution;
Cerebrospinal Fluid;
Dizziness;
Encephalitis, Varicella Zoster;
Epidemiology*;
Ganglion Cysts;
Headache;
Herpes Zoster;
Humans;
Immunoglobulin G;
Immunoglobulin M;
Incidence;
Medical Records;
Meningoencephalitis*;
Myalgia;
Neuralgia, Postherpetic;
Paralysis;
Trigeminal Nerve
- From:Korean Journal of Dermatology
2016;54(10):788-795
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Many studies about herpes zoster are available in Korean dermatological literature. However, only a few of them reported herpes zoster meningoencephalitis. OBJECTIVE: The aim of this study was to determine the epidemiology and clinical features of herpes-zoster meningoencephalitis compared with herpes zoster without meningoencephalitis. METHODS: We examined the medical records of 3,154 patients with herpes zoster, who had visited our hospital from January 2008 to March 2016. Among them, 159 patients underwent cerebrospinal fluid analysis. Fifty-one patients who were diagnosed with herpes zoster meningoencephalitis and the 3,103 patients who were without meningoencephalitis were subjected to examinations to assess the incidence rates, the age distribution, the ganglion distribution, severity of acute pain, postherpetic neuralgia, serum VZV IgM and IgG, the clinical aspects, the underlying diseases, and the presence of complications. RESULTS: The rate of herpes zoster meningoencephalitis was 1.61%, with a mean age of 53.95 years, and the female-to-male patient ratio was 1.68. The trigeminal nerve was the most frequently involved dermatome (53.7%), with the ophthalmic branch (V1) involved at a rate of 68.96% among them. The serum VZV IgM was significantly higher in herpes zoster meningoencephalitis compared with herpes zoster without meningoencephalitis. Dizziness, mental change, palsy, and myalgia with nausea/vomiting showed high predictive values. All the patients were treated with acyclovir for 10~14 days, and 1 of them expired (1.96%). CONCLUSION: The results of this study demonstrated that herpes-zoster meningoencephalitis was associated with high serum levels of VZV IgM compared with herpes zoster without meningoencephalitis. When a patient with herpes zoster has symptoms of headache and nausea/vomiting with dizziness, mental status change, palsy, or myalgia, herpes-zoster meningoencephalitis should be considered.
